2
Álvarez Padilla FN. Editorial: “Abordaje mininvasivo de la acalasia en estadio final”. Rev Argent Cir. 2025;117(1):1-3
8
en la selección de pacientes . Si bien la tendencia en ran la esofagocardioplasꢀa con otras técnicas como el
el manejo de la acalasia terminal orienta a evitar ciru- POEM, y la casuísꢀca se remite a pocos pacientes en
gías mayores, ya sea en primera instancia o en casos de general. Actualmente, las guías clínicas no consideran
persistencia de los síntomas posteriores al tratamiento, la esofagocardioplasꢀa como una opción de primera lí-
la esofagectomía conꢀnúa siendo de elección en casos nea, pero tampoco debería descartarse por completo.
con buen estado general, que no respondieron a otros En el contexto de la acalasia terminal aún quedan as-
procedimientos o que presentan lesiones preneoplási- pectos por deꢁnir, por lo que es fundamental adaptar
cas de alto riesgo de desarrollo de cáncer de esófago1
, 2
.
el tratamiento a cada paciente y a los recursos dispo-
La esofagocardioplasꢀa como técnica alter- nibles.
naꢀva previa a la esofagectomía fue propuesta por
En resumen, aunque la técnica propuesta por
diferentes autores con resultados alentadores, ya que los autores no es actualmente la opción de primera
disminuía el ꢀempo quirúrgico y la morbilidad en com- línea en el tratamiento de la acalasia terminal, podría
paración con la esofagectomía. El reflujo gastroesofá- ser considerada una alternaꢀva viable en determinadas
gico posterior al procedimiento puede ser controlado circunstancias. Se requiere mayor evidencia para vali-
con inhibidores de la bomba de protones en forma darla en el futuro, así como deꢁnir un contexto clínico y
9
, 10
saꢀsfactoria . Sin embargo, estos trabajos no compa- un patrón funcional especíꢁco para su implementación.
■
ENGLISH VERSION
Achalasia is a chronic disease for which there vary depending on the subtype of achalasia; therefore,
is no deꢁniꢀve cure to date. Therefore, its treatment misinterpreꢀng the manometric paꢃerns may affect the
focuses on minimizing symptoms, prevenꢀng therapeuꢀc outcomes. Type III achalasia is a condiꢀon
abnormal dilataꢀon of the organ, and reducing the that oꢄen requires a more extensive myotomy,
risk of esophageal cancer in these paꢀents. End-stage which can be more effecꢀvely achieved using POEM
achalasia not only results in anatomical changes to the (peroral endoscopic myotomy) compared to surgical
esophagus, but also causes a decline in the quality of myotomy1,2,4
life and nutriꢀonal status of those who reach this stage.
.
End-stage achalasia is the most severe form
5
This context in which paꢀents suffer clinical of presentaꢀon, with an esꢀmated incidence of 5% .
impairment makes management of end-stage Its main characterisꢀc is the marked and tortuous
achalasia difficult and controversial. Unfortunately, the dilataꢀon of the esophagus which adopts a sigmoid
available evidence does not allow one technique to be conꢁguraꢀon. Due to its low incidence, there is a lack
recommended over another. Therefore, the approach of evidence regarding its management and there is no
1
to these paꢀents depends on the experience of the deꢁnedtreatment . Inthissense, thestudypresentedby
work groups, the availability of personnel trained in the authors revisits techniques previously proposed in
advanced endoscopic techniques, and the performance the literature, which have shown promising short-term
1
status of the paꢀent requiring treatment .
results but have not been widely adopted. However,
The development of diagnosꢀc techniques with the development of POEM its implementaꢀon
such as high-resoluꢀon manometry (HRM), impedance- seems more difficult, as the results with therapeuꢀc
based techniques such as endo-FLIP, along with upper endoscopy are encouraging and comparable to those
6
gastrointesꢀnal endoscopy and convenꢀonal and achieved with myotomy as clinical experience grows .
dynamic barium esophagograms, has allowed a beꢃer However, POEM requires certain technical skills,
understanding of the mechanical phenomena and and not all centers have endoscopists trained in this
pressure changes that occur within the esophageal procedure, which limits its implementaꢀon.
2
lumen . High-resoluꢀon esophageal manometry is
As recommended by Rancés et al. in the study
7
the gold standard procedure for the diagnosis of the that moꢀvated this editorial , esophagectomy should be
different subtypes of achalasia, as described in the postponed as long as possible, while cardioplasty could
Chicago classiꢁcaꢀon in 2008 . This classiꢁcaꢀon clearly be a viable alternaꢀve if POEM is not possible or
divides achalasia into three well-deꢁned subtypes and if this or other treatments fail. The origin of persistent
is an important tool for therapeuꢀc decision-making.
2
,3
or recurrent symptoms must be correctly idenꢀꢁed,
An analysis of the various studies on the as they are not always due to incomplete dissecꢀon
management of this disease shows that there are of the sphincter but may also be influenced by factors
several therapeuꢀc opꢀons available to paꢀents. such as ꢁbrosis or reflux esophagiꢀs. Moreover, the
Undoubtedly, these opꢀons must be individualized for criteria for diagnosing therapeuꢀc failure are not
each case in a mulꢀdisciplinary approach and should clearly deꢁned. The Eckardt Score, widely used in the
not be limited to a generalized dissecꢀon of the lower literature to assess post-treatment symptoms, does
esophageal sphincter. The length of the myotomy will not differenꢀate between different causes of persistent